Activity of Tigecycline (GAR-936), a Novel Glycylcycline, against Enterococci in the Mouse Peritonitis Model

A novel glycylcycline agent, tigecycline (GAR-936), was evaluated in vivo in the mouse model of peritonitis against three Enterococcus faecalis and four Enterococcus faecium isolates with different susceptibilities to vancomycin and tetracyclines, all of which were inhibited by ≤0.125 μg of tigecycl...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Nannini, Esteban C., Pai, Suresh R., Singh, Kavindra V., Murray, Barbara E.
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2003
Soggetti:	Experimental Therapeutics
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC151755/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12543654/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.2.529-532.2003
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!